Background: Approximately 15% of women in the United States aged 35-79 year are at high risk for developing breast cancer, however less than 0.2% of these women reported taking chemoprevention to reduce their risk. Objective of the study was to characterize the current utilization of chemoprevention agents among hospitalized women who are at higher risk for breast cancer (5-year Gail risk score ≥1.7).
Methods: A cross sectional study at an academic hospital was conducted using bedside survey of 250 women aged 50-75 years. These women were cancer-free at the time of study enrollment and hospitalized to a general medicine service. Reproductive history, family history for breast cancer, chemopreventive agents use, and medical comorbidities data was collected for all patients. Chi square and t-tests were utilized to analyze population characteristics.
Results: Mean age for the study population was 61.5 years (SD 7.5), and mean 5-year Gail risk score was 1.67 (SD 0.88). A third of study population was at high risk for breast cancer. None of the high-risk women (0%) were taking chemoprevention for breast cancer risk reduction, and 23% were at very high risk with 5-year Gail score ≥ 3%. These women were not recognized as being high risk by their hospital providers and none were referred to the high risk breast cancer clinics following discharge.
Conclusions: Many hospitalized women are at high risk for breast cancer and we could not identify even a single woman who was using chemoprevention for risk reduction. Current chemoprevention guidelines may be falling short in their dissemination and implementation. Because women at high risk for breast cancer may only interface with the healthcare system at select points, all healthcare providers must be willing and able to do risk assessment. For those identified to be at high risk, providers must then either engage in chemopreventive counseling or refer patients to providers who are more comfortable working with patients on this critical decision.
To cite this abstract:Khaliq, W; Jelovac, D; Wright, S . PREVALENCE OF CHEMOPREVENTIVE AGENT USE AMONG HOSPITALIZED WOMEN AT HIGH RISK FOR BREAST CANCER: A CROSS-SECTIONAL STUDY. Abstract published at Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev. Abstract 83. Journal of Hospital Medicine. 2017; 12 (suppl 2). https://www.shmabstracts.com/abstract/prevalence-of-chemopreventive-agent-use-among-hospitalized-women-at-high-risk-for-breast-cancer-a-cross-sectional-study/. Accessed January 20, 2020.